Scentian Bio presents at ‘The Power of Innovation for a Post-Pandemic World’ showcase in Doha.

Scentian Bio was invited by the Bill & Melinda Gates Foundation to attend and present their technology at a high-level showcase held in Doha in December 2022. The showcase provided an opportunity for Scentian Bio to highlight the potential their technology has in changing the way the world diagnoses disease.

Chief Commercial Officer, Darja Pavlovic-Nelson was invited to attend the event and was interviewed on stage by Didier Drogba, former Chelsea player and philanthropist, about Scentian Bio’s technology and the role it could play in diagnosing and managing the next pandemic.

‘The Power of Innovation for a Post-Pandemic World’ event brought together health leaders, experts and innovators and football players on stage to highlight the lessons learned from the Covid-19 pandemic, to celebrate the scale and speed of scientific innovation over the past two years and discuss learnings and opportunities. A particular focus was highlighting the role science and technology can play helping to prevent a global pandemic in the future.

About Scentian Bio
Scentian Bio is the first company in the world to combine insect olfactory receptors with nanotechnology to taste and smell chemical compounds ultra-sensitively. Scentian Bio is developing portable biosensor devices for the real-time interpretation of complex chemical signatures. This biosensor platform is exclusively licensed from Plant & Food Research based in New Zealand and is backed by almost 20 years of fundamental research. This disruptive technology will improve the precision and speed of QC and new product development for the flavour & fragrance, and food & beverage industries. It also aims to impact human & animal health diagnostics, food safety monitoring, and water and air quality analysis. For more information visit www.scentianbio.com